No Data
No Data
No Data
No Data
No Data
Instil Bio Announces Board Reshuffle Following Resignation
TipRanksApr 27 04:14
Instil Bio Cut to Hold From Buy by Jefferies
Instil Bio Cut to Hold From Buy by Jefferies
Dow JonesApr 12 21:34
Jefferies Investment Bank: Downgraded the Instil Bio (TIL.US) rating from buy to hold, and adjusted the target price from $5.00 to $11.00.
Jefferies Investment Bank: Downgraded the Instil Bio (TIL.US) rating from buy to hold, and adjusted the target price from $5.00 to $11.00.
Zhitong FinanceApr 12 21:30
Jefferies Downgrades Instil Bio to Hold, Raises Price Target to $11
Jefferies analyst Kelly Shi downgrades Instil Bio (NASDAQ:TIL) from Buy to Hold and raises the price target from $5 to $11.
BenzingaApr 12 21:24
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)
TipRanksApr 12 17:20
HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $18 Price Target
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $18 price target.
BenzingaMar 25 18:08
No Data
No Data